Relmada Therapeutics, Inc. (RLMD)
7.235
+0.20
(+2.92%)
USD |
NASDAQ |
Apr 28, 16:00
7.235
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Price : 7.235 for April 28, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Catalyst Pharmaceuticals, Inc. | 29.43 |
| Theravance Biopharma, Inc. | 16.77 |
| Avalo Therapeutics, Inc. | 12.83 |
| AN2 Therapeutics, Inc. | 4.73 |
| ACADIA Pharmaceuticals, Inc. | 22.68 |
Price Related Metrics
| Price to Book Value | 8.772 |
| Earnings Yield | -20.32% |
| Market Cap | 758.88M |